Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Simulations Plus Inc (SLP)

Simulations Plus Inc (SLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 284,073
  • Shares Outstanding, K 20,147
  • Annual Sales, $ 79,180 K
  • Annual Income, $ -64,720 K
  • EBIT $ -70 M
  • EBITDA $ -62 M
  • 60-Month Beta 1.12
  • Price/Sales 3.71
  • Price/Cash Flow 10.18
  • Price/Book 2.31

Options Overview Details

View History
  • Implied Volatility 67.88% (-1.49%)
  • Historical Volatility 56.12%
  • IV Percentile 44%
  • IV Rank 29.66%
  • IV High 149.14% on 01/30/26
  • IV Low 33.61% on 02/19/25
  • Expected Move (DTE 10) 1.73 (12.25%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 12
  • Volume Avg (30-Day) 37
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 744
  • Open Int (30-Day) 1,031
  • Expected Range 12.42 to 15.88

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 02/28/26
See More
  • Average Estimate 0.27
  • Number of Estimates 2
  • High Estimate 0.31
  • Low Estimate 0.23
  • Prior Year 0.31
  • Growth Rate Est. (year over year) -12.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.51 +4.29%
on 02/09/26
21.01 -32.97%
on 01/23/26
-5.52 (-28.14%)
since 01/09/26
3-Month
13.51 +4.29%
on 02/09/26
21.01 -32.97%
on 01/23/26
-3.10 (-18.02%)
since 11/10/25
52-Week
12.39 +13.67%
on 07/18/25
37.67 -62.61%
on 02/14/25
-22.73 (-61.74%)
since 02/10/25

Most Recent Stories

More News
Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations

Extended projects support ongoing research into computational approaches and new approach methodologies for food and chemical safety assessment

SLP : 13.96 (-0.99%)
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

NEW YORK , Feb. 8, 2026 /PRNewswire/ --

SLP : 13.96 (-0.99%)
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

NEW YORK , Feb. 3, 2026 /PRNewswire/ --

SLP : 13.96 (-0.99%)
Simulations Plus to Participate in Upcoming Investor Conferences

Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced...

SLP : 13.96 (-0.99%)
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

NEW YORK , Jan. 29, 2026 /PRNewswire/ --

SLP : 13.96 (-0.99%)
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

NEW YORK , Jan. 23, 2026 /PRNewswire/ --

SLP : 13.96 (-0.99%)
Simulations Plus Highlights Platform Innovation and Strategic Direction at 2026 Investor Day

Showcases platform momentum, strategic priorities, and long-term value creation outlook

SLP : 13.96 (-0.99%)
Simulations Plus: Fiscal Q1 Earnings Snapshot

Simulations Plus: Fiscal Q1 Earnings Snapshot

SLP : 13.96 (-0.99%)
Simulations Plus Reports First Quarter Fiscal 2026 Financial Results

Investor Day on January 21, 2026, to present new product vision and AI solutions

SLP : 13.96 (-0.99%)
Simulations Plus in Minus Category on Word of Investor Day in January

Simulations Plus, Inc. (NASDAQ: SLP) shares lost ground Thursday. The company, a global leader in model-informed ...

SLP : 13.96 (-0.99%)

Business Summary

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab,...

See More

Key Turning Points

3rd Resistance Point 16.03
2nd Resistance Point 15.40
1st Resistance Point 14.75
Last Price 13.96
1st Support Level 13.48
2nd Support Level 12.85
3rd Support Level 12.20

See More

52-Week High 37.67
Fibonacci 61.8% 28.01
Fibonacci 50% 25.03
Fibonacci 38.2% 22.05
Last Price 13.96
52-Week Low 12.39

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar